Front-line treatment of advanced non-small cell lung cancer with docetaxel and Gemcitabine: A multicenter phase II trial

被引：0
|
作者：
Georgoulias, V [1 ]
Kourousis, C [1 ]
Kakolyris, S [1 ]
Dimopoulos, MA [1 ]
Papadakis, E [1 ]
Apostolopulou, F [1 ]
Agelidou, A [1 ]
Tzianni, V [1 ]
Sarra, E [1 ]
Vardakis, N [1 ]
机构：
[1] Univ Gen Hosp Heraklion, Dept Med Oncol, Greek Cooperat Grp Lung Canc, Heraklion 71110, Crete, Greece
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
453
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [41] Multicenter phase II study of gemcitabine, vinorelbine and ifosfamide in advanced non-small cell lung cancer
    Recchia, F
    Lombardo, M
    De Filippis, S
    Russelli, M
    Saggio, G
    Piccinini, M
    Rea, S
    ANNALS OF ONCOLOGY, 2000, 11 : 10 - 10
  • [42] Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)
    Valerie Israel
    Scott T. Tagawa
    Terry Snyder
    Susan Jeffers
    Derek Raghavan
    Investigational New Drugs, 2004, 22 : 291 - 297
  • [43] Phase II trial of gemcitabine, docetaxel, and cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Rubinsak, J. R.
    Spigel, D. R.
    Hainsworth, J. D.
    Webb, C.
    Inhorn, R. C.
    Infante, J. R.
    Yardley, D. A.
    Burris, H. A., III
    Vazquez, E. R.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)
    Israel, V
    Tagawa, ST
    Snyder, T
    Jeffers, S
    Raghavan, D
    INVESTIGATIONAL NEW DRUGS, 2004, 22 (03) : 291 - 297
  • [45] Pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC): A phase II clinical trial.
    McCleod, M
    Treat, J
    Christiansen, NP
    Mintzer, DM
    Bonomi, P
    Bloss, LP
    Taylor, L
    Monberg, MJ
    Ye, Z
    Obasaju, CK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 650S - 650S
  • [46] A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer
    Joppert, MG
    Garfield, DH
    Gregurich, MA
    Nemunaitis, JJ
    Marsland, TA
    Khandelwal, P
    Asmar, L
    LUNG CANCER, 2003, 39 (02) : 215 - 219
  • [47] Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancer
    Krug, LM
    Miller, VA
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 24 - 26
  • [48] Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA™) and cisplatin:: A multicenter phase II trial
    Manegold, C
    Gatzemeier, U
    von Pawel, J
    Pirker, R
    Malayeri, R
    Blatter, J
    Krejcy, K
    ANNALS OF ONCOLOGY, 2000, 11 (04) : 435 - 440
  • [49] Gemcitabine as second-line treatment for advanced non-small-cell lung cancer:: A phase II trial
    Crinò, L
    Mosconi, AM
    Scagliotti, G
    Selvaggi, G
    Novello, S
    Rinaldi, M
    Della Giulia, M
    Gridelli, C
    Rossi, A
    Calandri, C
    De Marinis, F
    Noseda, M
    Tonato, M
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2081 - 2085
  • [50] Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel-gemcitabine chemotherapy
    Pallis, A. G.
    Agelaki, S.
    Kakolyris, S.
    Kotsakis, A.
    Kalykaki, A.
    Vardakis, N.
    Papakotoulas, P.
    Agelidou, A.
    Geroyianni, A.
    Agelidou, M.
    Hatzidaki, D.
    Mavroudis, D.
    Georgoulias, V.
    LUNG CANCER, 2008, 62 (03) : 356 - 363
12345